Carol Scambler
Career history of Carol Scambler
Former positions of Carol Scambler
| Companies | Position | Start | End |
|---|---|---|---|
EnteroBiotix Ltd.
 EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Director/Board Member | - | - |
| Investor Relations Contact | - | - | |
| INDIGOVISION GROUP PLC | Human Resources Officer | 06/10/2009 | - |
Statistics
International
| United Kingdom | 3 |
Operational
| Human Resources Officer | 1 |
| Director/Board Member | 1 |
| Investor Relations Contact | 1 |
Sectoral
| Consumer Durables | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
IndigoVision Group Ltd.
 IndigoVision Group Ltd. Electronics/AppliancesConsumer Durables IndigoVision Group Plc engages in the development, manufacture, and sale of networked video security systems. It operates through the following geographical segments: Europe, Middle East, and Africa; North America; Latin America; and Asia Pacific. Its products include management software; artificial intelligence; management hardware; cameras and encoders; recorders; specialized cameras; body worn video; and integration. The company was founded by Oliver Richard Vellacott in 1994 and is headquartered in Edinburgh, the United Kingdom. | Consumer Durables |
EnteroBiotix Ltd.
EnteroBiotix Ltd. Medical SpecialtiesHealth Technology EnteroBiotix Ltd. develops novel microbiome modulating drugs which are composed of live microorganisms. It focuses on faecal microbiota transplantation which transfers bacteria from a healthy donor into a recipient having an infection caused by a bacterium called C.difficile. The company was founded by James Roger McIlroy in March 2017 and is headquartered in Aberdeen, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Carol Scambler
- Experience
